Moderna plan to crush Omicron

Moderna has unveiled a two-pronged approach to defeat the Omicron variant, using its current vaccine as a powerful third dose while simultaneously advancing an Omicron-specific booster to clinical trials in case it becomes necessary.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here